{
  "config": {
    "t0": 2024,
    "T": 2050,
    "dt": 1.0
  },
  "stages": [
    {
      "index": 1,
      "name": "Hypothesis Generation",
      "description": "Literature synthesis, pattern recognition, hypothesis formulation",
      "tau_baseline": 6.0,
      "M_max": 50.0,
      "p_success": 0.95,
      "k_saturation": 1.0,
      "mu_baseline": 2.0
    },
    {
      "index": 2,
      "name": "Experiment Design",
      "description": "Protocol development, methodology, controls",
      "tau_baseline": 3.0,
      "M_max": 20.0,
      "p_success": 0.9,
      "k_saturation": 1.0,
      "mu_baseline": 4.0
    },
    {
      "index": 3,
      "name": "Wet Lab Execution",
      "description": "Physical experiments, cell culture, animal studies",
      "tau_baseline": 12.0,
      "M_max": 5.0,
      "p_success": 0.3,
      "k_saturation": 0.5,
      "mu_baseline": 1.0
    },
    {
      "index": 4,
      "name": "Data Analysis",
      "description": "Statistical analysis, ML on experimental data",
      "tau_baseline": 2.0,
      "M_max": 100.0,
      "p_success": 0.95,
      "k_saturation": 1.0,
      "mu_baseline": 6.0
    },
    {
      "index": 5,
      "name": "Validation & Replication",
      "description": "Independent verification, peer review, publication",
      "tau_baseline": 8.0,
      "M_max": 5.0,
      "p_success": 0.5,
      "k_saturation": 0.5,
      "mu_baseline": 1.5
    },
    {
      "index": 6,
      "name": "Phase I Trials",
      "description": "Safety testing, dosing, small cohort (20-100 patients)",
      "tau_baseline": 12.0,
      "M_max": 4.0,
      "p_success": 0.66,
      "k_saturation": 0.5,
      "mu_baseline": 1.0
    },
    {
      "index": 7,
      "name": "Phase II Trials",
      "description": "Efficacy testing, dose optimization - 'valley of death'",
      "tau_baseline": 24.0,
      "M_max": 2.8,
      "p_success": 0.33,
      "k_saturation": 0.3,
      "mu_baseline": 0.5
    },
    {
      "index": 8,
      "name": "Phase III Trials",
      "description": "Confirmatory trials, large scale (1000-5000 patients)",
      "tau_baseline": 36.0,
      "M_max": 3.2,
      "p_success": 0.58,
      "k_saturation": 0.4,
      "mu_baseline": 0.3333333333333333
    },
    {
      "index": 9,
      "name": "Regulatory Approval",
      "description": "FDA/EMA review and approval process",
      "tau_baseline": 12.0,
      "M_max": 2.0,
      "p_success": 0.9,
      "k_saturation": 0.3,
      "mu_baseline": 1.0
    },
    {
      "index": 10,
      "name": "Deployment",
      "description": "Manufacturing scale-up, distribution, adoption",
      "tau_baseline": 12.0,
      "M_max": 4.0,
      "p_success": 0.95,
      "k_saturation": 0.5,
      "mu_baseline": 1.0
    }
  ],
  "scenarios": [
    {
      "name": "Pessimistic",
      "g_ai": 0.3,
      "description": "AI progress slows, institutional resistance, limited adoption"
    },
    {
      "name": "Baseline",
      "g_ai": 0.5,
      "description": "Current trends continue, moderate adoption"
    },
    {
      "name": "Optimistic",
      "g_ai": 0.7,
      "description": "AI breakthroughs, regulatory reform, rapid adoption"
    }
  ]
}